Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Violaine Havelange

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
American Journal of Hematology|October 14, 2010
MicroRNAs: emerging key regulators of hematopoiesisViolaine Havelange, Ramiro Garzon
Journal of Blood Medicine|August 27, 2013
Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophiliaViolaine Havelange, Jean-Baptiste Demoulin
Hematology (Amsterdam, Netherlands)|October 31, 2025
Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025Peter Vandenberghe, Dominiek Mazure, Gaëlle Vertenoeil, et al.
Hematology (Amsterdam, Netherlands)|December 27, 2021
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosisTimothy Devos, Dominik Selleslag, Nikki Granacher, et al.
Frontiers in Oncology|December 26, 2022
Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical managementGaël Vermeersch, Michel Delforge, Violaine Havelange, et al.
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Acta Clinica Belgica|April 14, 2017
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in BelgiumJohan Maertens, Carlos Graux, Dimitri Breems, et al.
International Journal of Molecular Sciences|June 2, 2021
MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by DaunorubicinEmeline Bollaert, Melissa Claus, Virginie Vandewalle, et al.
International Review of Cell and Molecular Biology|February 14, 2022
Targets in MPNs and potential therapeuticsGabriel Levy, Cristina Mambet, Christian Pecquet, et al.
Blood|July 28, 2011
IRF4 mutations in chronic lymphocytic leukemiaViolaine Havelange, Yuri Pekarsky, Tatsuya Nakamura, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
American Journal of Hematology|October 14, 2010
MicroRNAs: emerging key regulators of hematopoiesisViolaine Havelange, Ramiro Garzon
Journal of Blood Medicine|August 27, 2013
Review of current classification, molecular alterations, and tyrosine kinase inhibitor therapies in myeloproliferative disorders with hypereosinophiliaViolaine Havelange, Jean-Baptiste Demoulin
Hematology (Amsterdam, Netherlands)|October 31, 2025
Treatment of chronic myeloid leukemia chronic phase patients in third-line setting and beyond: recommendations from a Belgian expert panel in 2025Peter Vandenberghe, Dominiek Mazure, Gaëlle Vertenoeil, et al.
Hematology (Amsterdam, Netherlands)|December 27, 2021
Updated recommendations on the use of ruxolitinib for the treatment of myelofibrosisTimothy Devos, Dominik Selleslag, Nikki Granacher, et al.
Frontiers in Oncology|December 26, 2022
Case report: Chronic neutrophilic leukemia associated with monoclonal gammopathies. A case series and review of genetic characteristics and practical managementGaël Vermeersch, Michel Delforge, Violaine Havelange, et al.
Faculty Reviews|September 29, 2023
Recent advances in therapies for primary myelofibrosisWilliam Vainchenker, Nasrine Yahmi, Violaine Havelange, et al.
Acta Clinica Belgica|April 14, 2017
Retrospective chart review of hospitalizations and costs associated with the treatment of adults with Philadelphia-negative B-cell relapsed or refractory acute lymphoblastic leukemia in BelgiumJohan Maertens, Carlos Graux, Dimitri Breems, et al.
International Journal of Molecular Sciences|June 2, 2021
MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by DaunorubicinEmeline Bollaert, Melissa Claus, Virginie Vandewalle, et al.
International Review of Cell and Molecular Biology|February 14, 2022
Targets in MPNs and potential therapeuticsGabriel Levy, Cristina Mambet, Christian Pecquet, et al.
Blood|July 28, 2011
IRF4 mutations in chronic lymphocytic leukemiaViolaine Havelange, Yuri Pekarsky, Tatsuya Nakamura, et al.
Pageof 5